A Clostridium difficile infection “intervention”: Change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes
Authors:
- Zhuolin HanZhuolin Han
- Kathleen M. McMullenKMKathleen M. McMullen
- Anthony J. RussoARAnthony J. Russo
- Susan M. CopperSCSusan M. Copper
- David K. WarrenDavid K. Warren
- 1 May 2012
- journal article
- research article
- Published by Elsevier in American Journal of Infection Control
- Vol. 40 (4) , 349-353
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Effect of Hospital-Acquired Clostridium difficile Infection on In-Hospital MortalityArchives of internal medicine (1960), 2010
- Hospitals to report C. difficile and MRSA.2007
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for cultureJournal of Medical Microbiology, 2005
- Do physicians examine patients in contact isolation less frequently? A brief reportAmerican Journal of Infection Control, 2003
- Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficileClinical Infectious Diseases, 2002
- Adverse effects of contact isolationThe Lancet, 1999
- Perspective: Attributable Mortality—The Promise of Better Antimicrobial TherapyThe Journal of Infectious Diseases, 1998
- Clostridium Difficile-Associated Diarrhea and ColitisInfection Control & Hospital Epidemiology, 1995
- Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or MetronidazoleAnnals of Internal Medicine, 1992